Dana-Farber/Harvard Cancer Center for New Cancer Treatments
Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site)
This program helps bring new and promising cancer treatments to patients with advanced cancer through clinical trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11075362 on NIH RePORTER |
What this research studies
The Dana-Farber/Harvard Cancer Center is part of a national network that offers early-stage experimental treatments for advanced cancers. Our team includes experts in understanding cancer biology, developing new biomarkers, and conducting clinical trials. We work to identify and test innovative therapies, including those that target specific cancer pathways or boost the body's immune response. This effort aims to provide patients with access to cutting-edge options when standard treatments are no longer effective.
Who could benefit from this research
Good fit: Patients with advanced cancer who are seeking access to experimental therapies through clinical trials may be ideal candidates.
Not a fit: Patients whose cancer is well-controlled by existing treatments or who are not eligible for clinical trials may not directly benefit from this specific program.
Why it matters
Potential benefit: If successful, this program could lead to the discovery and development of more effective treatments for advanced cancers, offering new hope to patients.
How similar studies have performed: This program builds upon a successful history of participating in and leading numerous NCI-sponsored clinical trials, indicating a track record of advancing experimental therapeutics.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Shapiro, Geoffrey I. — Dana-Farber Cancer Inst
- Study coordinator: Shapiro, Geoffrey I.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.